UPDATE: Canaccord Genuity Initiates Coverage on Sunshine Heart with Buy Rating, $11 PT

Loading...
Loading...
In a report published Friday, Canaccord Genuity initiated coverage on Sunshine Heart
SSH
with a Buy rating and an $11.00 price target. Canaccord noted, “We initiate coverage of Sunshine Heart (SSH) with a BUY rating and 12-month price target of $11.00/share. SSH offers investors the opportunity to participate in a nascent growth company that is commercializing potentially disruptive technology for the treatment of Class III heart failure. The company's minimally invasive C-Pulse Assist System demonstrated solid results in its US feasibility trial, namely solid safety data, including no stroke or thrombus-related events. We recommend investors accumulate shares of SSH common ahead of important potential catalysts.” Sunshine Heart closed on Thursday at $6.85.
Posted In: Analyst ColorInitiationAnalyst RatingsCanaccord Genuity
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...